Drugs / TJP-008-1
last change Jul 2018 re-read 2 minutes ago

TJP-008-1

Investigated by
Taejoon Pharmaceutical Co., Ltd.

Trials 1 · a red edge is where a trial was stopped

201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT03544944 Jan → May 2018 Taejoon Pharmaceutical Co., Ltd. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TJP-008-1 ClinicalTrials.gov intervention name — accepted as the source's own label NCT03544944